Published in Proc Natl Acad Sci U S A on January 30, 2001
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A (2001) 24.34
ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia (2004) 17.08
Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci U S A (2004) 9.42
Coexpression analysis of human genes across many microarray data sets. Genome Res (2004) 9.38
Gene expression patterns in human liver cancers. Mol Biol Cell (2002) 6.93
Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci U S A (2003) 6.49
Ovarian cancer. Annu Rev Pathol (2009) 4.92
A versatile assay for high-throughput gene expression profiling on universal array matrices. Genome Res (2004) 4.19
Biomarker identification by feature wrappers. Genome Res (2001) 3.93
Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. Neoplasia (2005) 3.16
Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. Proc Natl Acad Sci U S A (2005) 2.75
Statistical modeling for selecting housekeeper genes. Genome Biol (2004) 2.73
Gene expression patterns in ovarian carcinomas. Mol Biol Cell (2003) 2.55
Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc Natl Acad Sci U S A (2003) 2.31
Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc Natl Acad Sci U S A (2007) 2.22
Molecular classification of familial non-BRCA1/BRCA2 breast cancer. Proc Natl Acad Sci U S A (2003) 2.10
The genetics of regulatory variation in the human genome. Hum Genomics (2005) 2.05
Tumour biological aspects of CD24, a mucin-like adhesion molecule. J Mol Histol (2004) 2.01
Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. Am J Pathol (2001) 1.95
Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma. Am J Pathol (2003) 1.94
Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol (2002) 1.94
CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival. Am J Pathol (2002) 1.85
Differential gene expression in ovarian carcinoma: identification of potential biomarkers. Am J Pathol (2004) 1.79
The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis. Br J Cancer (2011) 1.77
Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis. Proc Natl Acad Sci U S A (2003) 1.75
Large-scale integration of cancer microarray data identifies a robust common cancer signature. BMC Bioinformatics (2007) 1.74
Constructing gene co-expression networks and predicting functions of unknown genes by random matrix theory. BMC Bioinformatics (2007) 1.57
CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients. Br J Cancer (2003) 1.49
Tests for finding complex patterns of differential expression in cancers: towards individualized medicine. BMC Bioinformatics (2004) 1.49
Predicting biomarkers for ovarian cancer using gene-expression microarrays. Br J Cancer (2004) 1.47
A comparative study of different machine learning methods on microarray gene expression data. BMC Genomics (2008) 1.46
A miRNA-regulatory network explains how dysregulated miRNAs perturb oncogenic processes across diverse cancers. Genome Res (2012) 1.37
Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass. Obstet Gynecol (2011) 1.36
Of the atypical PKCs, Par-4 and p62: recent understandings of the biology and pathology of a PB1-dominated complex. Cell Death Differ (2009) 1.35
Transductional targeting of adenovirus vectors for gene therapy. Cancer Gene Ther (2006) 1.34
Integrated classification of lung tumors and cell lines by expression profiling. Proc Natl Acad Sci U S A (2002) 1.33
Cross-species hybridisation of pig RNA to human nylon microarrays. BMC Genomics (2002) 1.29
Bayesian rule learning for biomedical data mining. Bioinformatics (2010) 1.29
Increased cell migration and plasticity in Nrf2-deficient cancer cell lines. Oncogene (2010) 1.26
HtrA serine proteases as potential therapeutic targets in cancer. Curr Cancer Drug Targets (2009) 1.25
Identification of differentially expressed genes using an annealing control primer system in stage III serous ovarian carcinoma. BMC Cancer (2010) 1.21
Efficiency analysis of competing tests for finding differentially expressed genes in lung adenocarcinoma. Cancer Inform (2008) 1.21
Emerging Roles for SSeCKS/Gravin/AKAP12 in the Control of Cell Proliferation, Cancer Malignancy, and Barriergenesis. Genes Cancer (2010) 1.20
SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C- Raf/MEK/ERK pathway. J Biol Chem (2009) 1.19
Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome. Genes Chromosomes Cancer (2011) 1.18
Activation of MAP kinase signaling through ERK5 but not ERK1 expression is associated with lymph node metastases in oral squamous cell carcinoma (OSCC). Neoplasia (2008) 1.17
Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma. Neoplasia (2011) 1.17
HE4 as a biomarker for ovarian and endometrial cancer management. Expert Rev Mol Diagn (2009) 1.16
Predicting cancer involvement of genes from heterogeneous data. BMC Bioinformatics (2008) 1.16
Annexin 2 regulates intestinal epithelial cell spreading and wound closure through Rho-related signaling. Am J Pathol (2007) 1.15
Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling. Br J Cancer (2004) 1.14
Defining a comprehensive verotype using electronic health records for personalized medicine. J Am Med Inform Assoc (2013) 1.13
Filtering genes to improve sensitivity in oligonucleotide microarray data analysis. Nucleic Acids Res (2007) 1.12
Common human cancer genes discovered by integrated gene-expression analysis. PLoS One (2007) 1.11
Validation of cDNA microarray gene expression data obtained from linearly amplified RNA. Mol Pathol (2003) 1.11
NDRG2 inhibits hepatocellular carcinoma adhesion, migration and invasion by regulating CD24 expression. BMC Cancer (2011) 1.09
Selecting genes by test statistics. J Biomed Biotechnol (2005) 1.09
C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma. Br J Cancer (2008) 1.08
A-kinase anchoring proteins as potential drug targets. Br J Pharmacol (2012) 1.07
Genomic and proteomic approaches for studying human cancer: prospects for true patient-tailored therapy. Hum Genomics (2004) 1.05
Aberrant expression of homeobox gene HOXA7 is associated with müllerian-like differentiation of epithelial ovarian tumors and the generation of a specific autologous antibody response. Proc Natl Acad Sci U S A (2001) 1.05
Role of Bcl-3 in solid tumors. Mol Cancer (2011) 1.05
Computational prediction of human proteins that can be secreted into the bloodstream. Bioinformatics (2008) 1.04
World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project: IV. Tissue collection, processing, and storage in endometriosis research. Fertil Steril (2014) 1.03
Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancer. Br J Cancer (2006) 1.03
A Boolean-based systems biology approach to predict novel genes associated with cancer: Application to colorectal cancer. BMC Syst Biol (2011) 1.02
E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer. BMC Cancer (2010) 1.02
Molecular profiling of multiple human cancers defines an inflammatory cancer-associated molecular pattern and uncovers KPNA2 as a uniform poor prognostic cancer marker. PLoS One (2013) 0.98
cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma. Am J Pathol (2001) 0.97
Expression profiling of the ovarian surface kinome reveals candidate genes for early neoplastic changes. Transl Oncol (2009) 0.97
Reduced expression of a gene proliferation signature is associated with enhanced malignancy in colon cancer. Br J Cancer (2008) 0.96
Gene expression analysis in ovarian cancer - faults and hints from DNA microarray study. Front Oncol (2014) 0.96
Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy. Autophagy (2015) 0.95
A classification-based machine learning approach for the analysis of genome-wide expression data. Genome Res (2003) 0.95
Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker. Br J Cancer (2002) 0.95
Arrays of arrays for high-throughput gene expression profiling. Genome Res (2001) 0.95
Osteopontin is up-regulated and associated with neutrophil and macrophage infiltration in glioblastoma. Immunology (2010) 0.95
Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer. BMC Cancer (2009) 0.94
Gene expression profiling of epithelial ovarian tumours correlated with malignant potential. Mol Cancer (2004) 0.94
Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer. Gynecol Oncol (2011) 0.94
Clostridium perfringens enterotoxin carboxy-terminal fragment is a novel tumor-homing peptide for human ovarian cancer. BMC Cancer (2010) 0.92
PRK1 distribution in normal tissues and carcinomas: overexpression and activation in ovarian serous carcinoma. Hum Pathol (2009) 0.92
Differential activity of NADPH-producing dehydrogenases renders rodents unsuitable models to study IDH1R132 mutation effects in human glioblastoma. J Histochem Cytochem (2011) 0.90
Gene expression profiling of human ovarian tumours. Br J Cancer (2006) 0.90
A two-step strategy for detecting differential gene expression in cDNA microarray data. Curr Genet (2004) 0.89
Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients. Mol Cancer (2005) 0.89
Increased cell motility and invasion upon knockdown of lipolysis stimulated lipoprotein receptor (LSR) in SW780 bladder cancer cells. BMC Med Genomics (2008) 0.89
Claudins overexpression in ovarian cancer: potential targets for Clostridium Perfringens Enterotoxin (CPE) based diagnosis and therapy. Int J Mol Sci (2013) 0.89
Microarray analysis of B-cell lymphoma cell lines with the t(14;18). J Mol Diagn (2002) 0.88
MEIS2 is essential for neuroblastoma cell survival and proliferation by transcriptional control of M-phase progression. Cell Death Dis (2014) 0.88
Prediction of body fluids where proteins are secreted into based on protein interaction network. PLoS One (2011) 0.87
The molecular effect of metastasis suppressors on Src signaling and tumorigenesis: new therapeutic targets. Oncotarget (2015) 0.87
Distinct expression patterns in hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma. World J Gastroenterol (2008) 0.87
The effects of globin on microarray-based gene expression analysis of mouse blood. Mamm Genome (2010) 0.85
HE4 (WFDC2) gene overexpression promotes ovarian tumor growth. Sci Rep (2014) 0.85
Association between morphologic CT imaging traits and prognostically relevant gene signatures in women with high-grade serous ovarian cancer: a hypothesis-generating study. Radiology (2014) 0.84
Changes in gene expression associated with reproductive maturation in wild female baboons. Genome Biol Evol (2011) 0.84
Efficacy of a non-hypercalcemic vitamin-D2 derived anti-cancer agent (MT19c) and inhibition of fatty acid synthesis in an ovarian cancer xenograft model. PLoS One (2012) 0.83
Functional genomics as a tool in virus research. Indian J Microbiol (2008) 0.82
Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A (1998) 192.97
Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol (1996) 72.84
Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci U S A (1999) 35.16
High density synthetic oligonucleotide arrays. Nat Genet (1999) 29.99
Genome-wide expression monitoring in Saccharomyces cerevisiae. Nat Biotechnol (1997) 27.78
Molecular profiling of human cancer. Nat Rev Genet (2000) 2.64
Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas. Gene (1999) 2.45
Role of tumour markers in monitoring epithelial ovarian cancer. Br J Cancer (2000) 2.07
CD24 mediates rolling of breast carcinoma cells on P-selectin. FASEB J (1998) 1.95
Identification by cDNA microarray of genes involved in ovarian carcinogenesis. Cancer Res (2000) 1.81
An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. Cancer Res (2000) 1.81
Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix. Am J Obstet Gynecol (1984) 1.60
Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review). Int J Oncol (2000) 1.60
CD24, a signal-transducing molecule expressed on human B cells, is a major surface antigen on small cell lung carcinomas. Cancer Res (1992) 1.57
CD24 is a marker for human breast carcinoma. Cancer Lett (1999) 1.45
Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells. Cancer Res (1997) 1.39
Survival of European women with gynaecological tumours, during the period 1978-1989. EUROCARE Working Group. Eur J Cancer (1998) 1.26
Immunohistochemically detected expression of motility-related protein-1 (MRP-1/CD9) in lung adenocarcinoma and its relation to prognosis. Int J Cancer (1997) 1.10
CD9 is involved in invasion of human trophoblast-like choriocarcinoma cell line, BeWo cells. Mol Hum Reprod (1999) 1.00
Histopathology and molecular biology of ovarian epithelial tumors. Ann Diagn Pathol (1998) 0.98
Prognostic significance of DNA ploidy and S-phase fraction in malignant serous cystadenocarcinoma of the ovary. Anal Quant Cytol Histol (1998) 0.96
Aberrant FGF-2, FGF-3, FGF-4 and C-erb-B2 gene copy number in human ovarian, breast and endometrial tumours. Growth Factors (1996) 0.96
The selection of antibodies for targeted therapy of small-cell lung cancer (SCLC) using a human tumour spheroid model to compare the uptake of cluster 1 and cluster w4 antibodies. Br J Cancer (1994) 0.95
Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science (1999) 36.25
High density synthetic oligonucleotide arrays. Nat Genet (1999) 29.99
Genome-wide expression monitoring in Saccharomyces cerevisiae. Nat Biotechnol (1997) 27.78
A genome-wide transcriptional analysis of the mitotic cell cycle. Mol Cell (1998) 19.67
Accessing genetic information with high-density DNA arrays. Science (1996) 13.89
Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. Cell (2000) 13.44
Mitotic misregulation and human aging. Science (2000) 8.47
Replication dynamics of the yeast genome. Science (2001) 7.56
Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res (2001) 6.78
Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res (2001) 6.73
RNA expression analysis using a 30 base pair resolution Escherichia coli genome array. Nat Biotechnol (2000) 6.36
Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol (2000) 6.06
Direct allelic variation scanning of the yeast genome. Science (1998) 5.90
Transcriptional regulation and function during the human cell cycle. Nat Genet (2001) 5.89
Regional and strain-specific gene expression mapping in the adult mouse brain. Proc Natl Acad Sci U S A (2000) 5.01
Quantifying DNA-protein interactions by double-stranded DNA arrays. Nat Biotechnol (1999) 3.87
Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science (1998) 3.53
Parallel genotyping of human SNPs using generic high-density oligonucleotide tag arrays. Genome Res (2000) 2.79
Kinetic intermediates trapped by native interactions in RNA folding. Science (1998) 2.72
Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. J Natl Cancer Inst (1996) 2.30
Functional genomics. Proc Natl Acad Sci U S A (1999) 2.29
Effects of environmental enrichment on gene expression in the brain. Proc Natl Acad Sci U S A (2000) 2.13
Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays. Genome Res (2000) 2.13
Rapid isolation of human chromosome-specific DNA probes from a somatic cell hybrid. Genomics (1990) 1.99
Myoseverin, a microtubule-binding molecule with novel cellular effects. Nat Biotechnol (2000) 1.97
Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1. Cancer Res (2000) 1.87
Simultaneously detected endometrial and ovarian carcinomas--a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study. Gynecol Oncol (2001) 1.70
Features of cancer in nonagenarians and centenarians. J Am Geriatr Soc (1998) 1.61
Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer. Clin Cancer Res (2004) 1.56
Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma. Gynecol Oncol (1994) 1.56
The pharmacological chaperone 1-deoxygalactonojirimycin increases alpha-galactosidase A levels in Fabry patient cell lines. J Inherit Metab Dis (2009) 1.50
Parallel analysis of genetic selections using whole genome oligonucleotide arrays. Proc Natl Acad Sci U S A (1998) 1.48
The humoral hypercalcemia of benignancy. A newly appreciated syndrome. Am J Clin Pathol (1996) 1.47
Percutaneous pulmonary endoarterial biopsy in an experimental model of pulmonary hypertension. Chest (1998) 1.46
Calculation of electrostatic effects at the amino terminus of an alpha helix. Biophys J (1994) 1.43
Mutation detection by ligation to complete n-mer DNA arrays. Genome Res (1998) 1.41
Wnt signaling in ovarian tumorigenesis. Int J Gynecol Cancer (2007) 1.35
Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3. Cancer Res (1995) 1.26
Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome. Obstet Gynecol (1997) 1.19
Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer delays third-line chemotherapy and prolongs the platinum-free interval. Ann Oncol (2010) 1.15
Vaginal hysterectomy as primary treatment of endometrial cancer in medically compromised women. Obstet Gynecol (2001) 1.14
Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. Cancer Res (1995) 1.13
A defined region of loss of heterozygosity at 11q23 in cutaneous malignant melanoma. Cancer Res (1995) 1.04
Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis. Gynecol Oncol (1995) 1.04
Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism. Immunol Invest (1990) 1.01
Prognostic significance of human papillomavirus DNA in vulvar carcinoma. Obstet Gynecol (1995) 1.00
Identification and characterization of novel genes located at the t(1;15)(p36.2;q24) translocation breakpoint in the neuroblastoma cell line NGP. Genomics (2000) 0.99
Sclerosing mesenteritis: an unusual cause of abdominal pain in an HIV-positive patient. Am J Gastroenterol (1997) 0.98
Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus. Cancer (2000) 0.98
Analysis of replication error (RER+) phenotypes in cervical carcinoma. Cancer Res (1996) 0.97
Mutant yeast on drugs. Nat Med (1998) 0.97
Angiogenesis in gynecological oncology-mechanism of tumor progression and therapeutic targets. Int J Gynecol Cancer (2005) 0.96
Arrays of arrays for high-throughput gene expression profiling. Genome Res (2001) 0.95
CD4+ helper T cell depression in autism. Immunol Lett (1990) 0.94
A novel method for gene expression mapping of metastatic competence in human bladder cancer. Neoplasia (2006) 0.93
Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft model. Gynecol Oncol (2000) 0.93
Quantitative characterization of cells at the interface of long-term implants of selected polymers. J Biomed Mater Res (1986) 0.93
Immunogenetic studies in autism and related disorders. Mol Chem Neuropathol (1997) 0.92
Disseminated Mycobacterium avium complex: correlation between blood and tissue burden. J Infect Dis (1996) 0.92
Young age as a prognostic factor in cervical cancer: results of a population-based study. Am J Obstet Gynecol (1999) 0.91
High resolution analysis of chromosome 3p alterations in cervical carcinoma. Cancer Res (1997) 0.91
Evaluation of D-methionine as a cytoprotectant in cisplatin treatment of an animal model for ovarian cancer. Anticancer Res (2001) 0.91
Immunoenhancing properties and antiviral activity of 7-deazaguanosine in mice. Antimicrob Agents Chemother (1991) 0.90
Genetic alterations accumulate during cervical tumorigenesis and indicate a common origin for multifocal lesions. Cancer Res (1997) 0.90
Expression profiling of neural cells reveals specific patterns of ethanol-responsive gene expression. Mol Pharmacol (2000) 0.89
Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervix. Obstet Gynecol (2001) 0.89
Increased frequency of the extended or ancestral haplotype B44-SC30-DR4 in autism. Neuropsychobiology (1995) 0.89
Biomarker conservation in primary and metastatic epithelial ovarian cancer. Gynecol Oncol (2000) 0.89
Trimethoprim-sulfamethoxazole-induced vanishing bile duct syndrome. Am J Gastroenterol (1997) 0.89
Progressive murine cytomegalovirus disease after termination of ganciclovir therapy in mice immunosuppressed by cyclophosphamide treatment. J Infect Dis (1991) 0.88
Chipping away at complex behavior: transcriptome/phenotype correlations in the mouse brain. Physiol Behav (2001) 0.88
Strong association of the third hypervariable region of HLA-DR beta 1 with autism. J Neuroimmunol (1996) 0.87
Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro. J Immunol (1993) 0.87
Cervical cancer with paraaortic metastases: significance of residual paraaortic disease after surgical staging. Gynecol Oncol (1998) 0.87
Reimbursement for surgical procedures in gynecologic oncology. Curr Opin Oncol (2001) 0.87
Small bowel obstruction following radical hysterectomy: risk factors, incidence, and operative findings. Gynecol Oncol (1994) 0.87
HPV infection and number of lifetime sexual partners are strong predictors for 'natural' regression of CIN 2 and 3. Br J Cancer (2003) 0.86
Natural history of the minimally abnormal Papanicolaou smear. Obstet Gynecol (1992) 0.86
Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer. J Am Coll Surg (2001) 0.86
Brief report: immunoglobulin A deficiency in a subset of autistic subjects. J Autism Dev Disord (1997) 0.85
Evaluation of tamoxifen in persistent or recurrent nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Int J Gynecol Cancer (2004) 0.85
In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers. Gynecol Oncol (1998) 0.85
Loss of heterozygosity at the short arm of chromosome 3 in microdissected cervical intraepithelial neoplasia. Cancer Lett (2000) 0.84
Use of a modified ornithine decarboxylase promoter to achieve efficient c-MYC- or N-MYC-regulated protein expression. Cancer Res (2001) 0.84
Does human papillomavirus have a role in cancers of the uterine corpus? Gynecol Oncol (1999) 0.84